Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. NVDA
10. USO

Go back to Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
(NASDAQ: CODX) Delayed: 0.98 +0.04 (4.26%)
Previous Close $0.94    52 Week High $ 
Open $0.96    52 Week Low $ 
Day High $0.99    P/E N/A 
Day Low $0.91    EPS $ 
Volume 177,188